CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: Annual Report to Shareholders, page-5

  1. 5,843 Posts.
    lightbulb Created with Sketch. 409
    According to Layton , we won’t need a CR next year because we will be earning revenue from Dermacann. And yes the registry is tightly held , so when the good news does come , which it will , the share price will explode. Until then , we wait.
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.